Results 111 to 120 of about 2,458 (200)

Functional impact and molecular binding modes of drugs that target the PI3K isoform p110δ [PDF]

, 2023
Alvarez-Idaboy, Juan Raul, Blakemore, Stuart James, Farina-Morillas, Maria, Hallek, Michael, Hassenrück, Floyd, Krause, Günter, Landini, Francesco, Neumann, Lars, Pallasch, Christian P., Rabipour, Mina, Rebollido-Rios, Rocio   +10 more
core   +1 more source

Novel Approaches for the Treatment of Patients with Richter’s Syndrome [PDF]

, 2022
Deaglio, S., Iannello, A., Vaisitti, T.
core   +1 more source

Duvelisib Regimen [PDF]

, 2020
openaire   +1 more source

P1172: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA FROM THE PHASE 2 PRIMO TRIAL: UPDATED EXPANSION PHASE ANALYSIS

HemaSphere, 2022
P. L. Zinzani, MD, PhD, J. Zain, MD, M. Mead, BS, MD, C. Casulo, MD, E. D. Jacobsen, MD, G. Gritti, MD, PhD, L. Pinter-Brown, MD, K. Isutzu, MD, D. Cohan, MD, M. Daugherty, PharmD, J. E. Brammer, MD, N. Mehta-Shah, MD, B. Pro, MD, S. M. Horwitz, MD   +13 more
doaj   +1 more source

Molecular mechanisms and therapeutic targeting of Fc receptor activation in acute and chronic inflammatory diseases [PDF]

Antibodies play a crucial role in the host immune response against invading pathogens. By facilitating specific effector functions, they contribute to pathogen clearance and modulation of the immune response.
Geyer, C.E.
core  

Granuloma dual RNA-seq reveals composite transcriptional programs driven by neutrophils and necrosis within tuberculous granulomas. [PDF]

Sci Adv
Viswanathan G, Hughes EJ, Gan M, Xet-Mull AM, Lowy JP, Pyle CJ, Alexander G, Swain-Lenz D, Liu Q, Tobin DM.   +9 more
europepmc   +1 more source

Treatment Options of Mature, Nodal T-Cell Lymphomas [PDF]

, 2017
Illés, Árpád, Miltényi, Zsófia
core  

Chronic lymphocytic leukemia therapy: new targeted therapies on the way [PDF]

, 2016
Burger, Jan A., Vitale, Candida
core   +1 more source

P1124: DUVELISIB IN PATIENTS WITH RELAPSED/REFRACTORY PERIPHERAL T-CELL LYMPHOMA FROM THE PHASE 2 PRIMO TRIAL EXPANSION PHASE: OUTCOMES BY BASELINE HISTOLOGY

HemaSphere, 2023
Neha Mehta-Shah, Eric Jacobsen, Pier Luigi Zinzani, Jasmine Zain, Monica Mead, Carla Casulo, Giuseppi Gritti, Lauren Pinter-Brown, Koji Izutsu, Sheila Waters, Jonathan Brammer, Barbara Pro, Steven Horwitz   +12 more
doaj   +1 more source

Cutaneous and Systemic Complications in Primary CD8+ Aggressive Epidermotropic Cytotoxic T-cell Lymphoma. [PDF]

Cureus
Nikakis J, Islam Z, Coleman BA, Wang X, Mehtabdin K, Skopit S.   +5 more
europepmc   +1 more source